L and J-HZ by L&J Bio for Herpes Zoster (Shingles): Likelihood of Approval

L and J-HZ is under clinical development by L&J Bio and currently in Phase I for Herpes Zoster (Shingles).

Ono Pharmaceutical to acquire Deciphera Pharma, maker of cancer drugs, for $2.4 billion

Ono Pharmaceutical of Japan said Monday it will acquire Deciphera Pharmaceuticals, a Boston-based maker of cancer drugs, for $2.4 billion. The all-cash deal values Diciphera

April 29, 2024

Psychostimulant No Help in Relieving Cancer-Related Fatigue

Six weeks of treatment with methylphenidate did no better than placebo for improving cancer-related fatigue (CRF). The results continued a pattern of inconsistency in outcomes

May 23, 2024

FDA investigating whether CAR-T, a treatment for cancer, can also cause lymphoma

The Food and Drug Administration said Tuesday that it is investigating whether CAR-T therapy, which uses genetically modified white blood cells to attack tumors, can

November 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.